Main Content start here
Main Layout
Report Description

Report Description

United States heart valve devices market is expected to witness rapid growth during the forecast period owing to rising geriatric population coupled with increasing prevalence of various heart diseases and cardiovascular disorders. The presence of well-established healthcare infrastructure and easy access to advanced healthcare services is also acting as key growth driver for United States heart valve devices market. Furthermore, technological advancement in cardiac valve devices and introduction of newer, less invasive techniques to replace or repair heart valves is anticipated to drive the market growth in upcoming years. Also, rise in sedentary lifestyle, irregular eating habits and growing obese population are acting as major growth drivers for United States heart valve devices market.

Moreover, favorable reimbursement policies and launch of advanced heart valve devices are fueling the market growth. With growing awareness about benefits of valve replacement and rise in demand for minimally invasive surgeries, the United States heart valve devices market is anticipated to undergo substantial ACGR during the forecast period. However, the risk of infection due to cardiac implants and complications related to heart valves repair and replacement surgeries are expected to hamper the market growth.

United States heart valve devices market is categorized based on type, product type, valve type, procedure, application, end user and region. Based on type, the market can be segmented into mechanical heart valves, biological heart valves and transcatheter heart valves. Among them, transcatheter heart valves is anticipated to undergo significant growth during the forecast period owing to gradual shift towards minimally invasive surgeries, technological advancements and new product launches.

Based on end user, the United States heart valve devices market can be segmented into hospitals, ambulatory surgical centers and others. Among them, the hospital segment underwent highest growth in 2021 and is further expected to contribute to high revenue during he forecast period owing to favorable health reimbursements and increasing number of heart valve surgeries being performed.

Major players operating in the United States heart valve devices market include Abbott Laboratories, Inc., Boston Scientific Corporation, Cryolife, Inc., Edwards Lifesciences LLC, On-X Life Technologies, Inc., Micro Interventional Devices, Inc., Neovasc, Inc., Sorin Group USA, Inc., Medtronic, Inc. and St. Jude Medical, Inc., among others. The market players are focusing on new product launches and are undergoing mergers & acquisitions to increase their share in United States heart valve devices market.

Objective of the Study:

  • To analyze and estimate the market size of United States heart valve devices market from 2017 to 2020.
  • To estimate and forecast the market size of United States heart valve devices market from 2021 to 2027 and growth rate until 2027.
  • to classify and forecast United States heart valve devices market based on type, product type, valve type, procedure, application, end user, company and regional distribution.
  • To identify dominant region or segment in the United States heart valve devices market.
  • To identify drivers and challenges for United States heart valve devices market.
  • To examine competitive developments such as expansions, mergers & acquisitions, etc., in United States heart valve devices market.
  • To conduct pricing analysis for United States heart valve devices market.
  • To identify and analyze the profile of leading players operating in United States heart valve devices market.
  • To identify key sustainable strategies adopted by market players in United States heart valve devices market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of heart valve device manufacturers across United States. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of United States heart valve devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and end users for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Heart valve devices manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to heart valve devices
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as heart valve device manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.  

Attribute

Details

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022E

Forecast Period

2023F – 2027F

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022E-2027F

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

  • Type
  • Product Type
  • Valve Type
  • Procedure
  • Application
  • End User

Region Scope

South-Region, West-Region, Mid-West Region & Northeast-Region

Key Companies Profiled

Abbott Laboratories, Inc., Boston Scientific Corporation, Cryolife, Inc., Edwards Lifesciences LLC, On-X Life Technologies, Inc., Micro Interventional Devices, Inc., Neovasc, Inc., Sorin Group USA, Inc., Medtronic, Inc. and St. Jude Medical, Inc

Customization Scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, United States heart valve devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United States Heart Valve Devices Market, By Type:
    • Mechanical Heart Valves
    • Biological Heart Valves
    • Transcatheter Heart Valves
  • United States Heart Valve Devices Market, By Product Type:
    • Replacement
      • Aortic
      • Mitral
      • Others
    • Repair
  • United States Heart Valve Devices Market, By Valve Type:
    • Tissue Valve
    • Mechanical Valve
  • United States Heart Valve Devices Market, By Procedure:
    • Surgical
    • Transcatheter
  • United States Heart Valve Devices Market, By Application:
    • Aortic Stenosis
    • Aortic Regurgitation
    • Mitral Stenosis
    • Mitral Regurgitation
    • Pulmonary Valvular Heart Disease
  • United States Heart Valve Devices Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • United States Heart Valve Devices Market, By Region:
    • North-East
    • Mid-West
    • West
    • South

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States heart valve devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Heart Valve Devices Market

4.    Executive Summary

5.    Voice of Customer

6.    United States Heart Valve Devices Market Outlook

6.1.  Market Size & Forecast

6.1.1. By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Type (Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves)

6.2.2.     By Product Type (Replacement (Aortic, Mitral, Others), Repair)

6.2.3.     By Valve Type (Tissue Valve, Mechanical Valve)

6.2.4.     By Procedure (Surgical, Transcatheter)

6.2.5.     By Application (Aortic Stenosis, Aortic Regurgitation, Mitral Stenosis, Mitral Regurgitation, Pulmonary Valvular Heart Disease)

6.2.6.     By End User (Hospitals, Ambulatory Surgical Centers, Others)

6.2.7.     By Region

6.2.8.     By Company

6.3.  Product Market Map

7.    United States Mechanical Heart Valve Devices Market Outlook

7.1.  Market Size & Forecast

7.1.1. By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product Type

7.2.2.     By Valve Type

7.2.3.     By Procedure

7.2.4.     By Application

7.2.5.     By End User

7.3.  Pricing Analysis

8.    United States Biological Heart Valve Devices Market Outlook

8.1.  Market Size & Forecast

8.1.1. By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Product Type

8.2.3.     By Valve Type

8.2.4.     By Procedure

8.2.5.     By Application

8.2.6.     By End User

8.3.  Pricing Analysis

9.    United States Transcatheter Heart Valve Devices Market Outlook

9.1.  Market Size & Forecast

9.1.1. By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Product Type

9.2.3.     By Valve Type

9.2.4.     By Procedure

9.2.5.     By Application

9.2.6.     By End User

9.3.  Pricing Analysis

10.  Market Dynamics

10.1.              Drivers

10.2.              Challenges

11.  Market Trends & Development

12.  Policy & Regulatory Landscape

13.  Import Export Analysis

14.  United States Economic Profile

15.  Competitive Landscape

15.1.              Competition Outlook

15.2.              Company Profiles

15.2.1.  Abbott Laboratories, Inc.

15.2.2.  Boston Scientific Corporation

15.2.3.  Cryolife, Inc.

15.2.4.  Edwards Lifesciences LLC

15.2.5.  On-X Life Technologies, Inc.

15.2.6.  Micro Interventional Devices, Inc.

15.2.7.  Neovasc, Inc.

15.2.8.  Sorin Group USA, Inc.

15.2.9.  Medtronic, Inc.

15.2.10.                St. Jude Medical, Inc.

16.  Strategic Recommendations

(Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions

Frequently asked questions

Abbott Laboratories, Inc., Boston Scientific Corporation, Cryolife, Inc., Edwards Lifesciences LLC, On-X Life Technologies, Inc., Micro Interventional Devices, Inc., Neovasc, Inc., Sorin Group USA, Inc., Medtronic, Inc., and St. Jude Medical, Inc are the leading market players in the United States heart valve devices market.

Based on type, the market is divided into Mechanical Heart Valves, Biological Heart Valves, Transcatheter Heart Valves. Transcatheter Heart Valves are expected to dominate the market share during the forecast period.

Based on end user, the market is divided into Hospitals, Ambulatory Surgical Centers, Others. Hospitals are expected to hold the largest market during the forecast period.

The increasing prevalence of cardiovascular disorders and the growing geriatric population drive the United States heart valve devices market demand during the forecast period.

Related Reports